Trial of the efficacy and immunological response to an inactivated mycoplasma F38 vaccine.

Goats on two zero grazed farms carrying 1621 animals with a history of contagious caprine pleuropneumonia were subjected to a vaccine trial with an inactivated mycoplasma F38 vaccine. The results indicated that the vaccine produced an immune response, that it was very effective in reducing morbidity and mortality rates, and that a booster dose one month after the first dose of vaccine gave extra protection.

Treatment of contagious caprine pleuropneumonia.

A combination of dihydrostreptomycin sulphate (250 mg/ml) and penicillin G procaine (200,000 iu/ml) was used to treat contagious caprine pleuropneumonia caused by F38 strain of mycoplasma. A single dose of either 20, 30, 40 or 50 mg/kg body weight of the dihydrostreptomycin sulphate led to the recovery of the treated goats. The recovered goats did not transmit CCPP to susceptible goats housed with them for 2 months.